News | February 18, 2013

Team Creates MRI for the Nanoscale

A tiny defect, called a nitrogen vacancy (NV), inside a diamond enabled researchers to detect the magnetic resonance of organic molecules in the same way an MRI produces images of a tissue or an organ.

February 18, 2013 — Magnetic resonance imaging (MRI) reveals details of living tissues, diseased organs and tumors inside the body without X-rays or surgery. What if the same technology could peer down to the level of atoms? Doctors could make visual diagnoses of a person's molecules – examining damage on a strand of DNA, watching molecules misfold, or identifying a cancer cell by the proteins on its surface.

Now Carlos Meriles, associate professor of physics at The City College of New York, and an international team of researchers at the University of Stuttgart and elsewhere have opened the door for nanoscale MRI. They used tiny defects in diamonds to sense the magnetic resonance of molecules. They reported their results in the Feb. 1 issue of Science.

"It is bringing MRI to a level comparable to an atomic force microscope," said Meriles, referring to the device that traces the contours of atoms or tugs on a molecule to measure its strength. A nanoscale MRI could display how a molecule moves without touching it.

"Standard MRI typically gets to a resolution of 100 microns," about the width of a human hair, said Meriles. "With extraordinary effort," he said, "it can get down to about 10 microns" – the width of a couple of blood cells. Nanoscale MRI would have a resolution 1,000 to 10,000 times better.

To try to pick up magnetic resonance on such a small scale, the team took advantage of the spin of protons in an atom, a property usually used to investigate quantum computing. In particular, they used minute imperfections in diamonds.

Diamonds are crystals made up almost entirely of carbon atoms. When a nitrogen atom lodges next to a spot where a carbon atom is missing, however, it creates a defect known as a nitrogen-vacancy (NV) center.

"These imperfections turn out to have a spin — like a little compass — and have some remarkable properties," noted Meriles. In the last few years, researchers realized that these NV centers could serve as very sensitive sensors. They can pick up the magnetic resonance of nearby atoms in a cell, for example. But unlike the atoms in a cell, the NVs shine when a light is directed at them, signaling what their spin is. If you illuminate it with green light it flashes red back.

"It is a form of what is called optically detected magnetic resonance," he said. Like a hiker flashing Morse code on a hillside, the sensor "sends back flashes to say it is alive and well."

"The NV can also be thought of as an atomic magnet. You can manipulate the spin of that atomic magnet just like you do with MRI by applying a radio frequency or radio pulses," Meriles explained. The NV responds. Shine a green light at it when the spin is pointing up and it will respond with brighter red light. A down spin gives a dimmer red light.

Mireles has written on the theoretical underpinnings of the work and proposed the the project to the team, led by Professor Jörg Wrachtrup — a physicist at the University of Stuttgart in Germany — with the assistance of postdoctoral researcher Friedemann Reinhard and collaborators from the University of Bochum and the University of Science and Technology of China. Wrachtrup heads a leading group studying such defects.

In the lab, graduate student Tobias Staudacher — the first author in this work — used NVs that had been created just below the diamond's surface by bombarding it with nitrogen atoms. The team detected magnetic resonance within a film of organic material applied to the surface, just as one might examine a thin film of cells or tissue.

"Ultimately," said Meriles, "One will use a nitrogen-vacancy mounted on the tip of an atomic force microscope — or an array of NVs distributed on the diamond surface — to allow a scanning view of a cell, for example, to probe nuclear spins with a resolution down to a nanometer or perhaps better."

Related Content

Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI
Technology | Magnetic Resonance Imaging (MRI) | November 15, 2018
Canon Medical Systems USA Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on its new...
Life Image and Mendel.ai Bringing Artificial Intelligence to Clinical Trial Development
News | Artificial Intelligence | November 15, 2018
Life Image and Mendel.ai announced a new strategic partnership that will facilitate the adoption and enhancement of...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more